Michael G. Haddock, M.D., is a professor of radiation oncology with specialty interest in treatment of gastrointestinal and gynecologic malignancies as well as bone and soft tissue sarcoma. Specific clinical and research interests include:
Use of intraoperative radiation therapy to decrease the risk of local recurrence in locally advanced primary and recurrent pelvic and abdominal malignancies
Investigation of combined modality regimens for gastrointestinal and gynecologic malignancies
Dose escalation with intensity modulation or proton therapy to decrease the risk of local relapse
Use of intensity modulation and proton therapy to decrease overall treatment time and improve local tumor control
Application of high dose rate intra-cavitary and interstitial high dose rate brachytherapy for curative treatment of women with locally advanced or recurrent cervical, vaginal or endometrial cancer
Mathematical modeling of time, dose and fractionation to predict local control with alternative dose fractionation regimens
In additional to his clinical activities, Dr. Haddock has been very involved in cancer research through the cooperative groups of the National Cancer Institute and is currently the co-principal investigator for the Mayo Clinic NRG Oncology cooperative group. He is also actively involved in mentoring residents and fellows in the clinic and in research activities.